Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT

被引:4
|
作者
Meng, Qingcai [1 ,2 ,3 ,4 ]
Fang, Zengli [1 ,2 ,3 ,4 ]
Mao, Xiaoqi [1 ,2 ,3 ,4 ]
Tang, Rong [1 ,2 ,3 ,4 ]
Liang, Chen [1 ,2 ,3 ,4 ]
Hua, Jie [1 ,2 ,3 ,4 ]
Wang, Wei [1 ,2 ,3 ,4 ]
Shi, Si [1 ,2 ,3 ,4 ]
Yu, Xianjun [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Xu, Jin [1 ,2 ,3 ,4 ,8 ]
机构
[1] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China
[5] Chinese Study Grp Pancreat Canc CSPAC, 270 DongAn Rd, Shanghai 200032, Peoples R China
[6] Fudan Univ, Chair Dept Pancreat Surg, Shanghai Canc Ctr, 270 DongAn Rd, Shanghai 200032, Peoples R China
[7] Fudan Univ, Pancreat Cancer Inst, 270 DongAn Rd, Shanghai 200032, Peoples R China
[8] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, 270 DongAn Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
Cancer-associated fibroblasts; Pancreatic cancer; PET-CT; Metabolic reprogramming; AEROBIC GLYCOLYSIS; OXIDATIVE STRESS; STROMAL BIOLOGY; TUMOR-GROWTH; CAVEOLIN-1; MICROENVIRONMENT; LACTATE; AXIS;
D O I
10.1016/j.csbj.2023.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intratumor heterogeneity of positron emission tomography-computed tomography (PET-CT) is reflected by variable 18F-fluorodeoxyglucose (FDG) uptake. Increasing evidence has shown that neoplastic and non-neoplastic components can affect the total 18F-FDG uptake in tumors. Cancer-associated fibroblasts (CAFs) is considered as the main non-neoplastic components in tumor microenvironment (TME) of pancreatic cancer. Our study aims to explore the impact of metabolic changes in CAFs on heterogeneity of PET-CT. A total of 126 patients with pancreatic cancer underwent PET-CT and endoscopic ultrasound elastography (EUS-EG) before treatment. High maximum standardized uptake value (SUVmax) from the PET-CT was positively correlated with the EUS-derived strain ratio (SR) and indicated poor prognosis of patients. In addition, single-cell RNA analysis showed that CAV1 affected glycolytic activity and correlated with gly-colytic enzyme expression in fibroblasts in pancreatic cancer. We also observed the negative correlation between CAV1 and glycolytic enzyme expression in the tumor stroma by using immunohistochemistry (IHC) assay in the SUVmax-high and SUVmax-low groups of pancreatic cancer patients. Additionally, CAFs with high glycolytic activity contributed to pancreatic cancer cell migration, and blocking CAF glycolysis reversed this process, suggesting that glycolytic CAFs promote malignant biological behavior in pancreatic cancer. In summary, our research demonstrated that the metabolic reprogramming of CAFs affects total 18F-FDG uptake in tumors. Thus, an increase in glycolytic CAFs with decreased CAV1 expression promotes tumor progression, and high SUVmax may be a marker for therapy targeting the neoplastic stroma. Further studies should clarify the underlying mechanisms.(c) 2023 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creative-commons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:2631 / 2639
页数:9
相关论文
共 50 条
  • [31] The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors
    Mostafavi, Samaneh
    Zalpoor, Hamidreza
    Hassan, Zuhair Mohammad
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2022, 27 (01)
  • [32] Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
    Zhang, Tianyi
    Ren, Yanxian
    Yang, Pengfei
    Wang, Jufang
    Zhou, Heng
    CELL DEATH & DISEASE, 2022, 13 (10)
  • [33] Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
    Tianyi Zhang
    Yanxian Ren
    Pengfei Yang
    Jufang Wang
    Heng Zhou
    Cell Death & Disease, 13
  • [34] Cancer-associated fibroblasts enhance pancreatic cancer cell invasion by remodeling the metabolic conversion mechanism
    Shan, Tao
    Chen, Shuo
    Chen, Xi
    Lin, Wan Run
    Li, Wei
    Ma, Jiancang
    Wu, Tao
    Cui, Xijuan
    Ji, Hong
    Li, Yiming
    Kang, Ya'an
    ONCOLOGY REPORTS, 2017, 37 (04) : 1971 - 1979
  • [35] Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts
    Avagliano, Angelica
    Granato, Giuseppina
    Ruocco, Maria Rosaria
    Romano, Veronica
    Belviso, Immacolata
    Carfora, Antonia
    Montagnani, Stefania
    Arcucci, Alessandro
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [36] Identification of cancer-associated fibroblasts that suppress pancreatic cancer progression
    Enomoto, Atsushi
    Mizutani, Yasuyuki
    Kobayashi, Hiroki
    Iida, Tadashi
    Woods, Susan L.
    Worthley, Daniel L.
    Takahashi, Masahide
    CANCER RESEARCH, 2019, 79 (13)
  • [37] Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer
    Huang, Huocong
    Brekken, Rolf A.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2020, 319 (02): : C233 - C243
  • [38] Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?
    Qu, Chao
    Wang, Qing
    Meng, Zhiqiang
    Wang, Peng
    INTEGRATIVE CANCER THERAPIES, 2018, 17 (04) : 1016 - 1019
  • [39] The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer
    Sun, Qiqing
    Zhang, Bo
    Hu, Qiangsheng
    Qin, Yi
    Xu, Wenyan
    Liu, Wensheng
    Yu, Xianjun
    Xu, Jin
    THERANOSTICS, 2018, 8 (18): : 5072 - 5087
  • [40] Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer
    Zainab Hussain
    Thomas Bertran
    Pascal Finetti
    Eugenie Lohmann
    Emilie Mamessier
    Ghislain Bidaut
    François Bertucci
    Moacyr Rego
    Richard Tomasini
    Cell Communication and Signaling, 22